Table 2.
Clinical characteristics in the ICU before BSI.
| BSI Group (N = 48) | Non-BSI Group (N = 36) | p | |
|---|---|---|---|
| MV duration (days) | 8 (4, 11) | 7 (4, 12) | 0.895 |
| Invasive procedures | 2 (4) | 2 (6) | - |
| CVVHDF use | 9 (19) | 8 (22) | 0.786 |
| CVVHDF duration (days) | 5 (2, 9) | 4 (3, 5) | 0.843 |
| Steroids | 40 (83) | 33 (92) | 0.338 |
| Tocilizumab | 11 (23) | 13 (36) | 0.226 |
| Anakinra | 7 (15) | 12 (33) | 0.064 |
| Remdesivir | 12 (25) | 10 (28) | 0.806 |
Data is presented as median (25%, 75% quartiles) or n (%); BSI, Blood Stream Infection; ICU, Intensive Care Unit; MV, mechanical ventilation; CVVHDF, Continuous veno-venous hemodiafiltration; Invasive procedures, gastroscopy, colonoscopy, or bronchoscopy; p, comparison between the two groups. Results by univariate analysis, chi square test, or Fisher’s exact test for categorical variables and by Mann–Whitney U test for continuous variables.